In the latest session, Sotera Health Co (NASDAQ: SHC) closed at $14.59 up 0.21% from its previous closing price of $14.56. In other words, the price has increased by $+0.03 from its previous closing price. On the day, 3420094 shares were traded.
Ratios:
For a deeper understanding of Sotera Health Co’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.42. In the meantime, Its Debt-to-Equity ratio is 5.24 whereas as Long-Term Debt/Eq ratio is at 5.20.
On June 26, 2023, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $24.
JP Morgan Upgraded its Underweight to Neutral on January 23, 2023, whereas the target price for the stock was revised from $6 to $18.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 4.12B and an Enterprise Value of 6.15B. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 81.19, and their Forward P/E ratio for the next fiscal year is 16.53. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.77. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.93 while its Price-to-Book (P/B) ratio in mrq is 9.30. Its current Enterprise Value per Revenue stands at 5.86 whereas that against EBITDA is 15.11.
Stock Price History:
Over the past 52 weeks, SHC has reached a high of $19.40, while it has fallen to a 52-week low of $12.34. The 50-Day Moving Average of the stock is 15.84, while the 200-Day Moving Average is calculated to be 15.55.
Shares Statistics:
For the past three months, SHC has traded an average of 1.18M shares per day and 3.88M over the past ten days. A total of 282.83M shares are outstanding, with a floating share count of 98.47M. Insiders hold about 65.18% of the company’s shares, while institutions hold 28.65% stake in the company. Shares short for SHC as of Feb 15, 2024 were 12.02M with a Short Ratio of 10.16, compared to 9.74M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.25% and a Short% of Float of 12.05%.
Earnings Estimates
There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.13 for the current quarter, with a high estimate of $0.17 and a low estimate of $0.11, while EPS last year was $0.13. The consensus estimate for the next quarter is $0.18, with high estimates of $0.25 and low estimates of $0.16.
Analysts are recommending an EPS of between $0.91 and $0.7 for the fiscal current year, implying an average EPS of $0.74. EPS for the following year is $0.88, with 7 analysts recommending between $1.05 and $0.82.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $246.76M this quarter.It ranges from a high estimate of $255M to a low estimate of $234.8M. As of the current estimate, Sotera Health Co’s year-ago sales were $220.59M, an estimated increase of 11.90% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $274.53M, an increase of 7.50% less than the figure of $11.90% in the same quarter last year. There is a high estimate of $285.45M for the next quarter, whereas the lowest estimate is $265.71M.
A total of 7 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.1B, while the lowest revenue estimate was $1.09B, resulting in an average revenue estimate of $1.1B. In the same quarter a year ago, actual revenue was $1.05B, up 4.60% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.19B and the low estimate is $1.17B. The average revenue growth estimate for next year is up 7.10% from the average revenue estimate for this year.
